Home > > > Report Detail

Global Antibody Drug Conjugates (ADCs) Market Insights, Forecast to 2025

Publisher Name :
Date: 14-May-2019
No. of pages: 110
Inquire Before Buying

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue. ADCs are part of a specialized subset of highly potent APIs. This technically challenging type of therapy combines innovations from biotechnology and chemistry to form a new class of highly potent biopharmaceutical drugs.

Advances in coupling antibodies to cytotoxic drugs permit greater control of drug pharmacokinetics and significantly improve delivery to target tissue. Potent new anti-cancer drugs can now be used to target cancers while minimizing exposure of healthy tissue.

The global Antibody Drug Conjugates (ADCs) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antibody Drug Conjugates (ADCs) market based on company, product type, end user and key regions.

This report studies the global market size of Antibody Drug Conjugates (ADCs) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antibody Drug Conjugates (ADCs) in these regions.

This research report categorizes the global Antibody Drug Conjugates (ADCs) market by top players/brands, region, type and end user. This report also studies the global Antibody Drug Conjugates (ADCs) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Roche

- Pfizer

- Novartis

- Genmab

- Bayer

- Seattle Genetics

- Takeda Pharmaceuticals

- AbbVie

- AbGenomics

- ADC Therapeutics

- Astellas Pharma

- Kairos Therapeutics

Market size by Product

- Seattle Genetics Technology

- ImmunoGen Technology

- Immunomedics Technology

Market size by End User

- Hospital

- Clinics

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Antibody Drug Conjugates (ADCs) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Antibody Drug Conjugates (ADCs) market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Antibody Drug Conjugates (ADCs) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Antibody Drug Conjugates (ADCs) submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antibody Drug Conjugates (ADCs) are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antibody Drug Conjugates (ADCs) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Antibody Drug Conjugates (ADCs) Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Antibody Drug Conjugates (ADCs) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antibody Drug Conjugates (ADCs) Market Size Growth Rate by Product
1.4.2 Seattle Genetics Technology
1.4.3 ImmunoGen Technology
1.4.4 Immunomedics Technology
1.5 Market by End User
1.5.1 Global Antibody Drug Conjugates (ADCs) Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antibody Drug Conjugates (ADCs) Market Size
2.1.1 Global Antibody Drug Conjugates (ADCs) Revenue 2014-2025
2.1.2 Global Antibody Drug Conjugates (ADCs) Sales 2014-2025
2.2 Antibody Drug Conjugates (ADCs) Growth Rate by Regions
2.2.1 Global Antibody Drug Conjugates (ADCs) Sales by Regions
2.2.2 Global Antibody Drug Conjugates (ADCs) Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Antibody Drug Conjugates (ADCs) Sales by Manufacturers
3.1.1 Antibody Drug Conjugates (ADCs) Sales by Manufacturers
3.1.2 Antibody Drug Conjugates (ADCs) Sales Market Share by Manufacturers
3.1.3 Global Antibody Drug Conjugates (ADCs) Market Concentration Ratio (CR5 and HHI)
3.2 Antibody Drug Conjugates (ADCs) Revenue by Manufacturers
3.2.1 Antibody Drug Conjugates (ADCs) Revenue by Manufacturers (2014-2019)
3.2.2 Antibody Drug Conjugates (ADCs) Revenue Share by Manufacturers (2014-2019)
3.3 Antibody Drug Conjugates (ADCs) Price by Manufacturers
3.4 Antibody Drug Conjugates (ADCs) Manufacturing Base Distribution, Product Types
3.4.1 Antibody Drug Conjugates (ADCs) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibody Drug Conjugates (ADCs) Product Type
3.4.3 Date of International Manufacturers Enter into Antibody Drug Conjugates (ADCs) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Antibody Drug Conjugates (ADCs) Sales by Product
4.2 Global Antibody Drug Conjugates (ADCs) Revenue by Product
4.3 Antibody Drug Conjugates (ADCs) Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Antibody Drug Conjugates (ADCs) Breakdown Data by End User
6 North America
6.1 North America Antibody Drug Conjugates (ADCs) by Countries
6.1.1 North America Antibody Drug Conjugates (ADCs) Sales by Countries
6.1.2 North America Antibody Drug Conjugates (ADCs) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Antibody Drug Conjugates (ADCs) by Product
6.3 North America Antibody Drug Conjugates (ADCs) by End User
7 Europe
7.1 Europe Antibody Drug Conjugates (ADCs) by Countries
7.1.1 Europe Antibody Drug Conjugates (ADCs) Sales by Countries
7.1.2 Europe Antibody Drug Conjugates (ADCs) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibody Drug Conjugates (ADCs) by Product
7.3 Europe Antibody Drug Conjugates (ADCs) by End User
8 Asia Pacific
8.1 Asia Pacific Antibody Drug Conjugates (ADCs) by Countries
8.1.1 Asia Pacific Antibody Drug Conjugates (ADCs) Sales by Countries
8.1.2 Asia Pacific Antibody Drug Conjugates (ADCs) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Antibody Drug Conjugates (ADCs) by Product
8.3 Asia Pacific Antibody Drug Conjugates (ADCs) by End User
9 Central & South America
9.1 Central & South America Antibody Drug Conjugates (ADCs) by Countries
9.1.1 Central & South America Antibody Drug Conjugates (ADCs) Sales by Countries
9.1.2 Central & South America Antibody Drug Conjugates (ADCs) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Antibody Drug Conjugates (ADCs) by Product
9.3 Central & South America Antibody Drug Conjugates (ADCs) by End User
10 Middle East and Africa
10.1 Middle East and Africa Antibody Drug Conjugates (ADCs) by Countries
10.1.1 Middle East and Africa Antibody Drug Conjugates (ADCs) Sales by Countries
10.1.2 Middle East and Africa Antibody Drug Conjugates (ADCs) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Antibody Drug Conjugates (ADCs) by Product
10.3 Middle East and Africa Antibody Drug Conjugates (ADCs) by End User
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Company Business Overview
11.1.3 Roche Antibody Drug Conjugates (ADCs) Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Roche Antibody Drug Conjugates (ADCs) Products Offered
11.1.5 Roche Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Antibody Drug Conjugates (ADCs) Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Antibody Drug Conjugates (ADCs) Products Offered
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.3 Novartis Antibody Drug Conjugates (ADCs) Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Antibody Drug Conjugates (ADCs) Products Offered
11.3.5 Novartis Recent Development
11.4 Genmab
11.4.1 Genmab Company Details
11.4.2 Company Business Overview
11.4.3 Genmab Antibody Drug Conjugates (ADCs) Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Genmab Antibody Drug Conjugates (ADCs) Products Offered
11.4.5 Genmab Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Company Business Overview
11.5.3 Bayer Antibody Drug Conjugates (ADCs) Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Bayer Antibody Drug Conjugates (ADCs) Products Offered
11.5.5 Bayer Recent Development
11.6 Seattle Genetics
11.6.1 Seattle Genetics Company Details
11.6.2 Company Business Overview
11.6.3 Seattle Genetics Antibody Drug Conjugates (ADCs) Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Seattle Genetics Antibody Drug Conjugates (ADCs) Products Offered
11.6.5 Seattle Genetics Recent Development
11.7 Takeda Pharmaceuticals
11.7.1 Takeda Pharmaceuticals Company Details
11.7.2 Company Business Overview
11.7.3 Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Products Offered
11.7.5 Takeda Pharmaceuticals Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 Company Business Overview
11.8.3 AbbVie Antibody Drug Conjugates (ADCs) Sales, Revenue and Gross Margin (2014-2019)
11.8.4 AbbVie Antibody Drug Conjugates (ADCs) Products Offered
11.8.5 AbbVie Recent Development
11.9 AbGenomics
11.9.1 AbGenomics Company Details
11.9.2 Company Business Overview
11.9.3 AbGenomics Antibody Drug Conjugates (ADCs) Sales, Revenue and Gross Margin (2014-2019)
11.9.4 AbGenomics Antibody Drug Conjugates (ADCs) Products Offered
11.9.5 AbGenomics Recent Development
11.10 ADC Therapeutics
11.10.1 ADC Therapeutics Company Details
11.10.2 Company Business Overview
11.10.3 ADC Therapeutics Antibody Drug Conjugates (ADCs) Sales, Revenue and Gross Margin (2014-2019)
11.10.4 ADC Therapeutics Antibody Drug Conjugates (ADCs) Products Offered
11.10.5 ADC Therapeutics Recent Development
11.11 Astellas Pharma
11.12 Kairos Therapeutics
12 Future Forecast
12.1 Antibody Drug Conjugates (ADCs) Market Forecast by Regions
12.1.1 Global Antibody Drug Conjugates (ADCs) Sales Forecast by Regions 2019-2025
12.1.2 Global Antibody Drug Conjugates (ADCs) Revenue Forecast by Regions 2019-2025
12.2 Antibody Drug Conjugates (ADCs) Market Forecast by Product
12.2.1 Global Antibody Drug Conjugates (ADCs) Sales Forecast by Product 2019-2025
12.2.2 Global Antibody Drug Conjugates (ADCs) Revenue Forecast by Product 2019-2025
12.3 Antibody Drug Conjugates (ADCs) Market Forecast by End User
12.4 North America Antibody Drug Conjugates (ADCs) Forecast
12.5 Europe Antibody Drug Conjugates (ADCs) Forecast
12.6 Asia Pacific Antibody Drug Conjugates (ADCs) Forecast
12.7 Central & South America Antibody Drug Conjugates (ADCs) Forecast
12.8 Middle East and Africa Antibody Drug Conjugates (ADCs) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibody Drug Conjugates (ADCs) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Antibody Drug Conjugates (ADCs) Product Picture
Table Antibody Drug Conjugates (ADCs) Market Segments
Table Key Manufacturers Antibody Drug Conjugates (ADCs) Covered
Table Global Antibody Drug Conjugates (ADCs) Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Antibody Drug Conjugates (ADCs) Sales Market Share by Product 2014-2025
Figure Seattle Genetics Technology Product Picture
Table Major Manufacturers of Seattle Genetics Technology
Figure ImmunoGen Technology Product Picture
Table Major Manufacturers of ImmunoGen Technology
Figure Immunomedics Technology Product Picture
Table Major Manufacturers of Immunomedics Technology
Table Global Antibody Drug Conjugates (ADCs) Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital
Figure Clinics
Figure Others
Figure Antibody Drug Conjugates (ADCs) Report Years Considered
Figure Global Antibody Drug Conjugates (ADCs) Market Size 2014-2025 (Million US$)
Figure Global Antibody Drug Conjugates (ADCs) Sales 2014-2025 (K Units)
Table Global Antibody Drug Conjugates (ADCs) Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Antibody Drug Conjugates (ADCs) Sales by Regions 2014-2019 (K Units)
Table Global Antibody Drug Conjugates (ADCs) Sales Market Share by Regions 2014-2019
Figure Global Antibody Drug Conjugates (ADCs) Sales Market Share by Regions 2014-2019
Figure 2018 Global Antibody Drug Conjugates (ADCs) Sales Market Share by Regions
Table Global Antibody Drug Conjugates (ADCs) Revenue by Regions 2014-2019 (Million US$)
Table Global Antibody Drug Conjugates (ADCs) Revenue Market Share by Regions 2014-2019
Figure Global Antibody Drug Conjugates (ADCs) Revenue Market Share by Regions 2014-2019
Figure 2018 Global Antibody Drug Conjugates (ADCs) Revenue Market Share by Regions
Table Global Antibody Drug Conjugates (ADCs) Sales by Manufacturers (2014-2019) (K Units)
Table Global Antibody Drug Conjugates (ADCs) Sales Share by Manufacturers (2014-2019)
Figure Global Antibody Drug Conjugates (ADCs) Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Antibody Drug Conjugates (ADCs) Revenue by Manufacturers (2014-2019) (Million USD)
Table Antibody Drug Conjugates (ADCs) Revenue Share by Manufacturers (2014-2019)
Figure Antibody Drug Conjugates (ADCs) Value Share by Manufacturers in 2018
Table Key Manufacturers Antibody Drug Conjugates (ADCs) Price (2014-2019) (USD/Unit)
Table Antibody Drug Conjugates (ADCs) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Antibody Drug Conjugates (ADCs) Product Type
Table Date of International Manufacturers Enter into Antibody Drug Conjugates (ADCs) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Antibody Drug Conjugates (ADCs) Sales by Product (2014-2019) (K Units)
Table Global Antibody Drug Conjugates (ADCs) Sales Share by Product (2014-2019)
Figure Global Antibody Drug Conjugates (ADCs) Sales Market Share by Product (2014-2019)
Figure Global Antibody Drug Conjugates (ADCs) Sales Market Share by Product in 2018
Table Global Antibody Drug Conjugates (ADCs) Revenue by Product (2014-2019) (Million US$)
Table Global Antibody Drug Conjugates (ADCs) Revenue Share by Product (2014-2019)
Figure Global Antibody Drug Conjugates (ADCs) Revenue Market Share by Product (2014-2019)
Figure Global Antibody Drug Conjugates (ADCs) Revenue Market Share by Product in 2018
Table Antibody Drug Conjugates (ADCs) Price by Product 2014-2019 (USD/Unit)
Table Global Antibody Drug Conjugates (ADCs) Sales by End User (2014-2019) (K Units)
Table Global Antibody Drug Conjugates (ADCs) Sales Share by End User (2014-2019)
Figure Global Sales Antibody Drug Conjugates (ADCs) Market Share by End User (2014-2019)
Figure Global Sales Antibody Drug Conjugates (ADCs) Market Share by End User in 2018
Figure North America Antibody Drug Conjugates (ADCs) Sales Growth Rate 2014-2019 (K Units)
Figure North America Antibody Drug Conjugates (ADCs) Revenue Growth Rate 2014-2019 (Million US$)
Table North America Antibody Drug Conjugates (ADCs) Sales by Countries (2014-2019) (K Units)
Table North America Antibody Drug Conjugates (ADCs) Sales Market Share by Countries (2014-2019)
Figure 2018 North America Antibody Drug Conjugates (ADCs) Sales Market Share by Countries
Table North America Antibody Drug Conjugates (ADCs) Revenue by Countries (2014-2019) (Million US$)
Table North America Antibody Drug Conjugates (ADCs) Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Antibody Drug Conjugates (ADCs) Revenue Market Share by Countries
Figure United States Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure United States Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Canada Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Table North America Antibody Drug Conjugates (ADCs) Sales by Product (2014-2019) (K Units)
Table North America Antibody Drug Conjugates (ADCs) Sales Market Share by Product (2014-2019)
Figure 2018 North America Antibody Drug Conjugates (ADCs) Market Share by Product
Table North America Antibody Drug Conjugates (ADCs) Sales by End User (2014-2019) (K Units)
Table North America Antibody Drug Conjugates (ADCs) Sales Market Share by End User (2014-2019)
Figure 2018 North America Antibody Drug Conjugates (ADCs) Market Share by End User
Figure Europe Antibody Drug Conjugates (ADCs) Sales Growth Rate 2014-2019 (K Units)
Figure Europe Antibody Drug Conjugates (ADCs) Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Antibody Drug Conjugates (ADCs) Sales by Countries (2014-2019) (K Units)
Table Europe Antibody Drug Conjugates (ADCs) Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Antibody Drug Conjugates (ADCs) Sales Market Share by Countries
Table Europe Antibody Drug Conjugates (ADCs) Revenue by Countries (2014-2019) (Million US$)
Table Europe Antibody Drug Conjugates (ADCs) Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Antibody Drug Conjugates (ADCs) Revenue Market Share by Countries
Figure Germany Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Germany Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure France Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure France Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure UK Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Italy Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Russia Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Antibody Drug Conjugates (ADCs) Sales by Product (2014-2019) (K Units)
Table Europe Antibody Drug Conjugates (ADCs) Sales Market Share by Product (2014-2019)
Figure 2018 Europe Antibody Drug Conjugates (ADCs) Market Share by Product
Table Europe Antibody Drug Conjugates (ADCs) Sales by End User (2014-2019) (K Units)
Table Europe Antibody Drug Conjugates (ADCs) Sales Market Share by End User (2014-2019)
Figure 2018 Europe Antibody Drug Conjugates (ADCs) Market Share by End User
Figure Asia Pacific Antibody Drug Conjugates (ADCs) Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Antibody Drug Conjugates (ADCs) Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Antibody Drug Conjugates (ADCs) Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Antibody Drug Conjugates (ADCs) Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antibody Drug Conjugates (ADCs) Sales Market Share by Countries
Table Asia Pacific Antibody Drug Conjugates (ADCs) Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Antibody Drug Conjugates (ADCs) Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antibody Drug Conjugates (ADCs) Revenue Market Share by Countries
Figure China Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure China Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Japan Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Korea Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure India Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure India Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Australia Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Antibody Drug Conjugates (ADCs) Sales by Product (2014-2019) (K Units)
Table Asia Pacific Antibody Drug Conjugates (ADCs) Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Antibody Drug Conjugates (ADCs) Market Share by Product
Table Asia Pacific Antibody Drug Conjugates (ADCs) Sales by End User (2014-2019) (K Units)
Table Asia Pacific Antibody Drug Conjugates (ADCs) Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Antibody Drug Conjugates (ADCs) Market Share by End User
Figure Central & South America Antibody Drug Conjugates (ADCs) Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Antibody Drug Conjugates (ADCs) Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Antibody Drug Conjugates (ADCs) Sales by Countries (2014-2019) (K Units)
Table Central & South America Antibody Drug Conjugates (ADCs) Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antibody Drug Conjugates (ADCs) Sales Market Share by Countries
Table Central & South America Antibody Drug Conjugates (ADCs) Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Antibody Drug Conjugates (ADCs) Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antibody Drug Conjugates (ADCs) Revenue Market Share by Countries
Figure Brazil Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Antibody Drug Conjugates (ADCs) Sales by Product (2014-2019) (K Units)
Table Central & South America Antibody Drug Conjugates (ADCs) Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Antibody Drug Conjugates (ADCs) Market Share by Product
Table Central & South America Antibody Drug Conjugates (ADCs) Sales by End User (2014-2019) (K Units)
Table Central & South America Antibody Drug Conjugates (ADCs) Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Antibody Drug Conjugates (ADCs) Market Share by End User
Figure Middle East and Africa Antibody Drug Conjugates (ADCs) Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Antibody Drug Conjugates (ADCs) Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Antibody Drug Conjugates (ADCs) Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Antibody Drug Conjugates (ADCs) Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antibody Drug Conjugates (ADCs) Sales Market Share by Countries
Table Middle East and Africa Antibody Drug Conjugates (ADCs) Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Antibody Drug Conjugates (ADCs) Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antibody Drug Conjugates (ADCs) Revenue Market Share by Countries
Figure GCC Countries Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Antibody Drug Conjugates (ADCs) Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Antibody Drug Conjugates (ADCs) Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Antibody Drug Conjugates (ADCs) Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Antibody Drug Conjugates (ADCs) Market Share by Product
Table Middle East and Africa Antibody Drug Conjugates (ADCs) Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Antibody Drug Conjugates (ADCs) Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Antibody Drug Conjugates (ADCs) Market Share by End User
Table Roche Company Details
Table Roche Antibody Drug Conjugates (ADCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Pfizer Company Details
Table Pfizer Antibody Drug Conjugates (ADCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Antibody Drug Conjugates (ADCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Genmab Company Details
Table Genmab Antibody Drug Conjugates (ADCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Genmab Recent Development
Table Bayer Company Details
Table Bayer Antibody Drug Conjugates (ADCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Seattle Genetics Company Details
Table Seattle Genetics Antibody Drug Conjugates (ADCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Seattle Genetics Recent Development
Table Takeda Pharmaceuticals Company Details
Table Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Takeda Pharmaceuticals Recent Development
Table AbbVie Company Details
Table AbbVie Antibody Drug Conjugates (ADCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table AbGenomics Company Details
Table AbGenomics Antibody Drug Conjugates (ADCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbGenomics Recent Development
Table ADC Therapeutics Company Details
Table ADC Therapeutics Antibody Drug Conjugates (ADCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table ADC Therapeutics Recent Development
Table Astellas Pharma Company Details
Table Kairos Therapeutics Company Details
Table Global Antibody Drug Conjugates (ADCs) Sales Forecast by Regions 2019-2025 (K Units)
Table Global Antibody Drug Conjugates (ADCs) Sales Market Share Forecast by Regions 2019-2025
Table Global Antibody Drug Conjugates (ADCs) Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Antibody Drug Conjugates (ADCs) Revenue Market Share Forecast by Regions 2019-2025
Table Global Antibody Drug Conjugates (ADCs) Sales Forecast by Product 2019-2025 (K Units)
Table Global Antibody Drug Conjugates (ADCs) Sales Market Share Forecast by Product 2019-2025
Table Global Antibody Drug Conjugates (ADCs) Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Antibody Drug Conjugates (ADCs) Revenue Market Share Forecast by Product 2019-2025
Table Global Antibody Drug Conjugates (ADCs) Sales Forecast by End User 2019-2025 (K Units)
Table Global Antibody Drug Conjugates (ADCs) Sales Market Share Forecast by End User 2019-2025
Figure North America Antibody Drug Conjugates (ADCs) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Antibody Drug Conjugates (ADCs) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Antibody Drug Conjugates (ADCs) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Antibody Drug Conjugates (ADCs) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Antibody Drug Conjugates (ADCs) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Antibody Drug Conjugates (ADCs) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Antibody Drug Conjugates (ADCs) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Antibody Drug Conjugates (ADCs) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Antibody Drug Conjugates (ADCs) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Antibody Drug Conjugates (ADCs) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Antibody Drug Conjugates (ADCs) Value Chain
Table Antibody Drug Conjugates (ADCs) Customers List
Table Antibody Drug Conjugates (ADCs) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs